Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter Phase I Trial of 17-N-allylamino-17-demethoxy Geldanamycin (17-AAG, NSC #330507) in Patients With Recurrent/Refractory Pediatric Solid Tumors (Ewing's Sarcoma, Desmoplastic Small Round Cell Tumor, Osteosarcoma, Neuroblastoma, and Rhabdomyosarcoma) and Leukemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00093821
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:30.072751+00:00
Published At
2013-06-04T00:00:00+00:00
Record Updated At
2013-06-04
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Childhood Chronic Myelogenous Leukemia", "Childhood Desmoplastic Small Round Cell Tumor", "Disseminated Neuroblastoma", "Metastatic Childhood Soft Tissue Sarcoma", "Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor", "Metastatic Osteosarcoma", "Previously Treated Childhood Rhabdomyosarcoma", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Recurrent Childhood Rhabdomyosarcoma", "Recurrent Childhood Soft Tissue Sarcoma", "Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor", "Recurrent Neuroblastoma", "Recurrent Osteosarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-06-04"
protocolSection.identificationModule.nctId
"NCT00093821"
protocolSection.identificationModule.officialTitle
"A Multicenter Phase I Trial of 17-N-allylamino-17-demethoxy Geldanamycin (17-AAG, NSC #330507) in Patients With Recurrent/Refractory Pediatric Solid Tumors (Ewing\u0027s Sarcoma, Desmoplastic Small Round Cell Tumor, Osteosarcoma, Neuroblastoma, and Rhabdomyosarcoma) and Leukemia"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Childhood Chronic Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • Childhood Desmoplastic Small Round Cell Tumor (protocolSection.conditionsModule.conditions)
  • Disseminated Neuroblastoma (protocolSection.conditionsModule.conditions)
  • Metastatic Childhood Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
  • Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (protocolSection.conditionsModule.conditions)
  • Metastatic Osteosarcoma (protocolSection.conditionsModule.conditions)
  • Previously Treated Childhood Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
  • Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent Neuroblastoma (protocolSection.conditionsModule.conditions)
  • Recurrent Osteosarcoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.